JPY4,372.00
0.34% yesterday
Tokyo, Jun 27, 08:13 am CET
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Takeda Pharmaceutical Stock price

JPY4,366.00
+166.00 3.95% 1M
+178.00 4.25% 6M
+185.00 4.42% YTD
+208.00 5.00% 1Y
+590.00 15.63% 3Y
+484.00 12.47% 5Y
-1,470.00 25.19% 10Y
-1,004.00 18.70% 20Y
Tokyo, Closing price Fri, Jun 27 2025
+9.00 0.21%
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Key metrics

Basic
Market capitalization
JPY6.9t
Enterprise Value
JPY11.0t
Net debt
JPY4.1t
Cash
JPY405.6b
Shares outstanding
1.6b
Valuation (TTM | estimate)
P/E
63.90 | 29.46
P/S
1.51 | 1.49
EV/Sales
2.40 | 2.38
EV/FCF
15.53
P/B
0.99
Dividends
DPS
JPY200.00
Yield 1Y | 5Y
4.58% | 4.70%
Growth 1Y | 5Y
2.04% | 2.13%
Payout 1Y | 3Y
286.76% | 155.64%
Increased
3 Years
Financials (TTM | estimate)
Revenue
JPY4.6t | JPY4.6t
EBITDA
JPY957.4b | JPY1.2t
EBIT
JPY342.6b
Net Income
JPY107.9b | JPY233.2b
Free Cash Flow
JPY709.3b
Growth (TTM | estimate)
Revenue
7.45% | 1.01%
EBITDA
4.05% | 23.93%
EBIT
-14.05%
Net Income
-25.08% | 116.12%
Free Cash Flow
201.06%
Margin (TTM | estimate)
Gross
65.51%
EBITDA
20.90% | 26.40%
EBIT
7.48%
Net
2.36% | 5.04%
Free Cash Flow
15.48%
Financial Health
Equity Ratio
48.67%
Return on Equity
1.56%
ROCE
2.92%
ROIC
1.78%
Debt/Equity
0.65
More
EPS
JPY68.33
FCF per Share
JPY450.76
Short interest
-
Employees
49.28k
Rev per Employee
JPY92.97m
Show more

Is Takeda Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Takeda Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Takeda Pharmaceutical forecast:

12x Buy
57%
9x Hold
43%

Analyst Opinions

21 Analysts have issued a Takeda Pharmaceutical forecast:

Buy
57%
Hold
43%

Financial data from Takeda Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,581,551 4,581,551
7% 7%
100%
- Direct Costs 1,580,217 1,580,217
11% 11%
34%
3,001,334 3,001,334
6% 6%
66%
- Selling and Administrative Expenses 1,104,766 1,104,766
5% 5%
24%
- Research and Development Expense 730,227 730,227
0% 0%
16%
957,357 957,357
4% 4%
21%
- Depreciation and Amortization 614,771 614,771
18% 18%
13%
EBIT (Operating Income) EBIT 342,586 342,586
14% 14%
7%
Net Profit 107,928 107,928
25% 25%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Takeda Pharmaceutical Stock News

AD HOC NEWS
5 months ago
Takeda Pharmaceutical Company Limited / JP3463000004

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today